John L. Andreassi
Vertex Pharmaceuticals
2 Papers
John L. Andreassi is an academic researcher from Vertex Pharmaceuticals. The author has contributed to research in topics: Adrenoleukodystrophy & Very long chain fatty acid. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.
Jon H. Come,Timothy J. Senter,Michael P. Clark,John J. Court,Gale-Day Zachary,Wenxin Gu,Elaine Krueger,Jianglin Liang,Morris Mark A,Suganthini Nanthakumar,Hardwin O'dowd,Francois Maltais,Ganesh Iyer,John L. Andreassi,Christina Boucher,Tony Considine,Cameron Stuver Moody,William P. Taylor,Arun K. Mohanty,Yulin Huang,Harmon J. Zuccola,Joyce T. Coll,Kenneth C. Bonanno,Gagnon Kevin James,Lu Gan,Fan Lu,Hong Gao,Ananthisrinivas Chakilam,Juntyma J. Engtrakul,Bin Song,Dan Crawford,Elisabeth Doyle,Tal Kramer,Bryan W. Vought,Jonathan A. Phillips,Raymond Kemper,Martin Sanders,Swett Rebecca Jane,Brinley Furey,Ray Winquist,Mark Edward Bunnage,Katrina L. Jackson,Paul S. Charifson,Sanjay Shivayogi Magavi +43 more
TL;DR: In this paper, the authors explored a series of thiazole amides that evolved into compound 27, a highly potent, central nervous system (CNS)-penetrant compound with favorable in vivo pharmacokinetics.
5